PDCD1 and colorectal cancer: Patients with end-stage colorectal cancer treated simultaneously with 68% hydrogen and 32% oxygen were found to have an increased ratio of programmed cell death-1 (PD-1)-/CD8+ T cells in the peripheral blood, significantly longer progression-free survival, and improved prognosis (60).